Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Paus

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Movement Disorders : Official Journal of the Movement Disorder Society|December 20, 2008
Genetic association study of the P-type ATPase ATP13A2 in late-onset Parkinson's diseaseAleksandar Rakovic, Barbara Stiller, Ana Djarmati, et al.
Frontiers in Neurology|January 1, 2024
Botulinum neurotoxin type A in the interdisciplinary treatment of sialorrhea in adults and children-update and practice recommendationsWolfgang H Jost, Tobias Bäumer, Andrea Bevot, et al.
Neurology. Genetics|December 13, 2021
Transcript-Specific Loss-of-Function Variants in <i>VPS16</i> Are Enriched in Patients With DystoniaJoohyun Park, Annemarie Reilaender, Jan N Petry-Schmelzer, et al.
Journal of Clinical Medicine|May 14, 2022
Aneurysmal Subarachnoid Hemorrhage during the Shutdown for COVID-19Erdem Güresir, Ingo Gräff, Matthias Seidel, et al.
Journal of Neurology|October 28, 2016
Botulinum toxin therapy for treatment of spasticity in multiple sclerosis: review and recommendations of the IAB-Interdisciplinary Working Group for Movement Disorders task forceDirk Dressler, Roongroj Bhidayasiri, Saeed Bohlega, et al.
Journal of Neurology|February 10, 2018
Defining spasticity: a new approach considering current movement disorders terminology and botulinum toxin therapyDirk Dressler, Roongroj Bhidayasiri, Saeed Bohlega, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Movement Disorders : Official Journal of the Movement Disorder Society|December 20, 2008
Genetic association study of the P-type ATPase ATP13A2 in late-onset Parkinson's diseaseAleksandar Rakovic, Barbara Stiller, Ana Djarmati, et al.
Frontiers in Neurology|January 1, 2024
Botulinum neurotoxin type A in the interdisciplinary treatment of sialorrhea in adults and children-update and practice recommendationsWolfgang H Jost, Tobias Bäumer, Andrea Bevot, et al.
Neurology. Genetics|December 13, 2021
Transcript-Specific Loss-of-Function Variants in <i>VPS16</i> Are Enriched in Patients With DystoniaJoohyun Park, Annemarie Reilaender, Jan N Petry-Schmelzer, et al.
Journal of Clinical Medicine|May 14, 2022
Aneurysmal Subarachnoid Hemorrhage during the Shutdown for COVID-19Erdem Güresir, Ingo Gräff, Matthias Seidel, et al.
Journal of Neurology|October 28, 2016
Botulinum toxin therapy for treatment of spasticity in multiple sclerosis: review and recommendations of the IAB-Interdisciplinary Working Group for Movement Disorders task forceDirk Dressler, Roongroj Bhidayasiri, Saeed Bohlega, et al.
Journal of Neurology|February 10, 2018
Defining spasticity: a new approach considering current movement disorders terminology and botulinum toxin therapyDirk Dressler, Roongroj Bhidayasiri, Saeed Bohlega, et al.
Pageof 5